Table 2.
Clinical characteristics of critically ill COVID-19 patients on mortality status.
| Variable | Survived (n = 6) | Non-survived (n = 22) | p |
|---|---|---|---|
| Age, years | 63 (±8) | 61 (±12) | .746 |
| Gender (male, n, %) | 3 (50) | 13 (59) | 1 |
| BMI (kg/m2), mean (±SD) | 27.57 (±4.4) | 26.58 (±3.24) | .542 |
| Smoker, n (%) | 0 (0) | 7 (32) | .111 |
| Severely affected lung (right, n, %) | 4 (66) | 15 (68) | .944 |
| Comorbidities | |||
| Diabetes mellitus, n (%) | 4 (66) | 12 (54) | .595 |
| Hypertension, n (%) | 4 (66) | 10 (50) | .357 |
| Chronic kidney disease, n (%) | 1 (17) | 9 (41) | .272 |
| Scoring system | |||
| APACHE II score, mean (±SD) | 13.50 (±3.73) | 16.60 (±5.07) | .178 |
| mSOFA score, median (IQR) | 8.00 (8.00–8.00) | 9.00 (8.00–10.00) | .052 |
| CCI, mean (±SD) | 5.00 (±2.45) | 4.59 (±2.15) | .691 |
SD: standard deviation; IQR: interquartile range; APACHE: acute physiology and chronic health evaluation; mSOFA: modified sequential organ failure assessment; CCI: comorbidity channel index.